Literature DB >> 3108891

Active immunization against renin in normotensive marmoset.

J B Michel, C Guettier, M Philippe, F X Galen, P Corvol, J Ménard.   

Abstract

Primate renins (human and monkey) are very similar. We used pure human renin to immunize marmosets (Callithrix jacchus) and thereby produce a chronic blockade of the renin-angiotensinogen reaction. After a control period of 2 months, five male marmosets, on their usual sodium-poor diet, were immunized against pure human renin by three subcutaneous injections of 30 micrograms each, with complete and then incomplete Freund's adjuvant. Three marmosets were injected with adjuvant only and served as controls. Blood sampling and blood pressure measurements were performed weekly. After the third injection, the five marmosets immunized against renin developed a high titer of renin antibodies (50% binding of 125I-labeled human renin at a dilution of greater than or equal to 1:10,000). The antibodies inhibited the enzymatic activity of both marmoset and human renins. At the same time, systolic blood pressure decreased significantly from 125 +/- 13 mm Hg to 87 +/- 8 mm Hg (mean +/- SD; 1 mm Hg = 133 Pa). Plasma renin enzyme activity was undetectable in three animals. Plasma aldosterone decreased significantly. After 1-4 months with low blood pressure, a normal urinary output, and a normal plasma creatinine, the five marmosets became sick and died within one month. At autopsy an immunological renal disease, characterized by the presence of immunoglobulin and macrophage infiltration colocalized with renin, was found. Granulomatous formations, probably due to Freund's adjuvant, could be seen in the lungs and in the kidney. No immunoglobulin was detectable in extrarenal vessels or in other organs. These experiments demonstrate that, in this primate, a chronic blockade of the renin-angiotensin system can be achieved by active immunization against homologous renin, but this blockade is associated with the development of an autoimmune disease localized in the kidney.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108891      PMCID: PMC305082          DOI: 10.1073/pnas.84.12.4346

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  ALDOSTERONE SECRETION IN DOGS IMMUNIZED WITH HOG RENIN.

Authors:  W F GANONG; T C LEE; E E VANBRUNT; E G BIGLIERI
Journal:  Endocrinology       Date:  1965-06       Impact factor: 4.736

2.  Juxtaglomerular cell changes in dogs with antirenin titers.

Authors:  H E SCHMID
Journal:  Circ Res       Date:  1962-11       Impact factor: 17.367

3.  Effect of adjuvant (Freund's type) and its components on the organs of various animal species; a comparative study.

Authors:  A LAUFER; C TAL; A J BEHAR
Journal:  Br J Exp Pathol       Date:  1959-02

4.  Renin and antirenin in treatment of long term experimental renal hypertension in the dog.

Authors:  S H KREMEN; G E WAKERLIN
Journal:  Proc Soc Exp Biol Med       Date:  1955-10

5.  Antibodies to renin as proof of the pathogenesis of sustained renal hypertension.

Authors:  G E WAKERLIN
Journal:  Circulation       Date:  1958-04       Impact factor: 29.690

6.  Renin concentration of normotensive and hypertensive dog kidney: its relation to serum antirenin titer.

Authors:  H E SCHMID; L GRAHAM; B B BRENNAN; G E WAKERLIN
Journal:  Circ Res       Date:  1962-04       Impact factor: 17.367

7.  Urinary excretion of aldosterone in dogs with elevated plasma titers of antirenin.

Authors:  A W Gomoll; H E Schmid
Journal:  Proc Soc Exp Biol Med       Date:  1965-11

8.  Effects of immunisation against luteinising hormone releasing hormone on reproduction of the marmoset monkey Callithrixjacchus.

Authors:  J K Hodges; J P Hearn
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

9.  Macrophage locomotion in experimental allergic thyroiditis of the rat.

Authors:  H Fujiwara; M Sakata; Y Tomooka; M Tanaka; M Torisu
Journal:  Clin Immunol Immunopathol       Date:  1982-03

10.  Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.

Authors:  J Burton; R J Cody; J A Herd; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

View more
  12 in total

Review 1.  Success and failure of vaccines against renin-angiotensin system components.

Authors:  Morris J Brown
Journal:  Nat Rev Cardiol       Date:  2009-08-25       Impact factor: 32.419

Review 2.  Vaccination: a novel strategy for inhibiting the renin-angiotensin-aldosterone system.

Authors:  Alan H Gradman; Rehka Pinto
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 3.  Hypertension Vaccine may be a boon to millions in developing world.

Authors:  Mohan Bairwa; Manju Pilania; Vivek Gupta; Kapil Yadav
Journal:  Hum Vaccin Immunother       Date:  2013-12-23       Impact factor: 3.452

Review 4.  Renin inhibition: a new modality for hypertension management.

Authors:  Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

5.  Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice.

Authors:  Futoshi Nakagami; Hiroshi Koriyama; Hironori Nakagami; Mariana Kiomy Osako; Munehisa Shimamura; Mariko Kyutoku; Takashi Miyake; Tomohiro Katsuya; Hiromi Rakugi; Ryuichi Morishita
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

6.  Therapeutic vaccines against human and rat renin in spontaneously hypertensive rats.

Authors:  Zhihua Qiu; Xiao Chen; Yanzhao Zhou; Jibin Lin; Dan Ding; Shijun Yang; Fen Chen; Min Wang; Feng Zhu; Xian Yu; Zihua Zhou; Yuhua Liao
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 7.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

Review 8.  Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.

Authors:  Quynh N Dinh; Grant R Drummond; Christopher G Sobey; Sophocles Chrissobolis
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 9.  Therapeutic Vaccines for Hypertension: a New Option for Clinical Practice.

Authors:  Hironori Nakagami; Ryuichi Morishita
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 4.592

Review 10.  Peptide Vaccines for Hypertension and Diabetes Mellitus.

Authors:  Hironori Nakagami; Hiroshi Koriyama; Ryuichi Morishita
Journal:  Vaccines (Basel)       Date:  2014-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.